Consolidated Balance Sheets - USD ($) $ in Thousands	Dec. 31, 2024	Dec. 31, 2023
Current assets:
Cash and cash equivalents	$ 88,559	$ 92,154
Accounts receivable, net	81,886	129,122
Prepaid expenses and other current assets	11,923	12,012
Total current assets	182,368	233,288
Property and equipment, net	4,495	5,585
Operating lease right-of-use assets	11,028	12,586
Intangible assets, net	2,860	3,682
Deferred tax assets	144,234	212,324
Other assets	5,923	3,608
Total assets	350,908	471,073
Current liabilities:
Accounts payable	2,127	7,830
Accrued research and development costs	6,681	21,331
Accrued expenses and other current liabilities	26,849	44,254
Current portion of operating lease liabilities	3,189	3,126
Current portion of convertible senior notes		199,560
Total current liabilities	38,846	276,101
Convertible senior notes, net of current portion	198,988	198,309
Operating lease obligations, net of current portion	12,304	14,543
Revolving credit facility	385,000	300,000
Other liabilities	17,105	28,415
Commitments and contingencies
Stockholders' deficit:
Preferred stock, $0.001 par value, 75,000,000 shares authorized, no shares issued and outstanding
Class A Common Stock, $0.001 par value, 500,000,000 shares authorized and 160,205,899 shares issued and outstanding at December 31, 2024 and 500,000,000 shares authorized and 156,354,238 shares issued and outstanding at December 31, 2023	160	156
Additional paid-in capital	1,395,317	1,355,195
Accumulated deficit	(1,697,735)	(1,698,615)
Accumulated other comprehensive loss	923	(3,031)
Total stockholders' deficit	(301,335)	(346,295)
Total liabilities and stockholders' deficit	$ 350,908	$ 471,073